YIELD10 BIOSCIENCE, INC. YTEN Cash Flow

Yield10 bioscience, inc. (YTEN)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities
Cash flows from operating activities
Net loss
-3,600	-	-	-	-2,260	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-445	-1,185	-473	-663	-	-	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,807	-6,708	-6,762	-7,491	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-2,638	-2,393	-2,292	-	-2,025	-2,727	-2,092	-	4,024	-3,198	-6,498	-	-5,848	-6,073	-5,843	-	-7,893	-7,235	-8,154	-	-7,251	-7,865	-6,763	-9,517	-7,745	-7,948	28,840	-9,603	-9,560	-9,982	-9,640
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation
48	53	50	50	50	50	50	49	47	48	52	53	53	57	186	150	122	98	67	45	55	77	97	142	191	191	206	236	295	272	308	339	379	373	364	386	384
Change in fair value of warrants
957	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of fixed assets
-206	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Charge for 401(k) company common stock match
42	25	24	25	24	11	21	24	46	17	22	23	23	22	27	77	155	32	73	81	137	42	73	90	169	41	88	88	180	58	86	102	162	40	121	126	242
Stock-based compensation
137	250	131	113	162	229	356	315	281	332	400	399	264	-307	254	310	591	645	589	581	313	364	533	594	785	681	764	814	863	844	852	979	1,104	1,059	1,132	1,209	1,233
Non-cash lease expense
151	1,169	157	152	147	157	286	85	60	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax provision
30	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivables
-18	1	-77	103	-49	69	25	-42	-12	-81	-78	3	144	-132	-112	38	34	-38	137	-35	129	-183	-345	127	-551	496	165	-441	-62	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	449	-87	-	398	36	14
Due from related parties
-	-	-	-	-	-	-	-	-	0	0	0	-1	0	-27	-176	58	-1	57	-4	-18	12	100	0	-51	-40	91	0	-75	75	0	-136	-175	-17	102	-279	265
Unbilled receivables
105	-63	-20	24	13	37	-14	7	-29	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled receivables
-	-	-	-	-	-	-	-	-	-	7	-19	-7	-226	244	50	-97	-138	-58	-212	138	257	14	-108	60	-84	-547	-115	561	-295	146	-23	240	-	-	-	-
Inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-197	-24	41	11	22	-16	-15	-271	-163	161	-189	139	114	-157	420	-740	207	-156	2,977	-	-	-	-
Prepaid expenses and other assets
69	208	-227	-50	60	58	14	-69	125	55	-173	-639	97	111	-370	-763	-280	394	-188	857	18	297	-237	-451	434	-174	3	174	18	-14	109	-89	-114	361	-125	-208	-96
Accounts payable
-144	228	-4	43	-105	78	5	-15	-27	25	-22	19	-5	-173	-1,151	1,202	71	-274	213	-120	-45	-35	-64	-73	-74	157	320	10	-1,141	993	-373	424	-323	-16	-54	578	-235
Accrued expenses
259	454	150	-10	-92	-316	170	67	-993	206	-663	3	-168	202	1,094	-1,090	-1,051	44	535	611	-1,128	176	386	630	-2,371	1,743	-15	592	-937	67	574	210	-885	-82	181	698	-1,420
Lease liabilities
-236	-	-	-	-198	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
18	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from options exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23	12	36
Lease liabilities
-	-	-	-	-	-	-68	-94	-68	-	-31	-278	-275	-316	805	0	-150	0	0	0	0	0	0	-12	-38	103	-178	-38	-38	-	-	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,509	-4,816	-4,935	-8,431	-5,034	-4,329	-5,796	-8,498	-5,960	-6,281	-5,884	-12,259	-8,607	-7,825	-5,937	-9,362
Net cash used by discontinued operations for operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-385	20	54	-534	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used for operating activities
-2,288	-3,209	-1,368	-1,781	-2,296	-2,023	-1,843	-1,858	-3,030	-1,893	-2,023	-1,853	-2,433	-	-4,371	-1,090	-6,526	-	-4,264	-5,468	-6,661	-5,894	-4,796	-4,881	-8,965	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities
Cash flows from investing activities
Purchase of property and equipment
42	49	-1	13	0	0	8	31	3	0	6	0	0	31	332	228	161	156	289	82	127	19	53	0	100	92	11	206	64	-5	110	139	148	268	139	173	315
Proceeds from sale of property and equipment
10	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-494	0	307	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of short-term investments
503	4,704	2	998	0	1,754	1,756	3,984	4,002	0	0	0	0	-	-	-	-	-	-	-	-	0	0	0	1,508	1,014	5,041	5,565	5,015	2,505	8,493	19,695	28,240	13,589	14,920	70,466	8,502
Proceeds from the sale and maturity of short-term investments
750	-996	1,000	0	2,746	3,500	3,750	1,489	11	0	0	0	0	-	-	-	-	-	-	-	-	-2	0	6,813	6,206	6,374	7,938	2,989	19,520	6,983	20,113	28,246	28,961	26,352	20,506	26,943	25,663
Net cash provided (used) by continuing operations for investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-82	-127	22	-53	6,813	4,598	5,268	2,886	-2,807	14,441	4,483	11,550	8,412	573	12,495	5,447	-43,696	16,846
Net cash provided by investing activities
215	-5,749	999	-1,011	2,746	1,746	1,986	-2,526	-3,994	0	-6	0	0	-31	10,448	-197	-468	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities
Proceeds from warrants exercised (Note 11)
928	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from warrants exercised
-	-	-	-	-	0	0	0	124	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from warrants exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	300	0	0	9	5	0	0	8	11	-	-	-	-
Proceeds from registered direct offering, net of issuance costs
0	-	0	-14	2,597	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent and other long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-37	-39	-39	-	-38	-38	-39
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-882	615	-10	123	-92	-3	102	-158	-422	-43	101	219	-79	-443	-95	109	662	94	-38,656	-2	404	635	296
Net cash provided by financing activities
928	11,500	0	-18	2,597	0	0	-6	124	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-55	-2	-6	-3	-5	-6	-5	-10	-4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (decrease) increase in cash, cash equivalents and restricted cash
-1,200	2,540	-375	-2,813	3,042	-283	138	-4,400	-6,904	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	1,966	-12	0	-	-	-	-	-	-	-	-	1	24,913	0	300	0	0	9	5	0	0	8	11	3	-1	49,369	36
Effect of exchange rate changes on cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-	-	3	1	-1	-3	-3	-2	-4	1	-3	0	-1	139	-109	-7	-25	-8	-2	-10	-8	-4	4	-8	2	-6	-7	-5	1
Net decrease in cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-	-	-60	-1,864	-2,434	-2,473	6,074	-1,563	-6,998	-5,625	-4,813	9,450	-6,789	-5,440	19,955	1,925	-4,092	-1,174	-3,036	-8,604	5,940	-2,833	5,273	2,528	-11,673	3,885	-2,386	-269	7,521
Supplemental Disclosure of Non-cash Information:
Purchase of property and equipment included in accounts payable and accrued expenses
0	-	-	-	12	-	-	-	31	-	-	-	0	-	-	301	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs remaining in accrued expenses
0	-	-	-	14	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-